CD8A and malignant colon neoplasm: As such, B cells, CD4+, and CD8+ T cells have been associated with improved clinical outcomes whereas regulatory cell types, such as regulatory T cells and neutrophils, have been associated with poor outcome in ovarian, breast, lung, and colon cancers [54–57].